News & Updates
Filter by Specialty:
Adjuvant atezolizumab improves DFS in early-stage NSCLC
In patients with completely resected stage II–IIIA non-small-cell lung cancer (NSCLC) who had previously received adjuvant cisplatin chemotherapy, adjuvant atezolizumab extended disease-free survival (DFS), particularly in those with PD-L1 expression ≥1 percent on tumour cells, interim results of the phase III IMpower010 trial showed.
Adjuvant atezolizumab improves DFS in early-stage NSCLC
27 Oct 2021Overweight, obesity during pregnancy up offspring’s NAFLD risk
Overweight or obesity during pregnancy increases the risk of future nonalcoholic fatty liver disease (NAFLD) in the offspring, a recent Sweden study has found.
Overweight, obesity during pregnancy up offspring’s NAFLD risk
27 Oct 2021Helmet-CPAP safely improves oxygenation in pregnant women with COVID-19 respiratory failure
Administrating continuous positive airway pressure (CPAP) through a helmet (h-CPAP) device safely improves oxygenation in women with moderate-to-severe acute respiratory failure (ARF) due to the coronavirus disease 2019 (COVID-19), a recent study has found.
Helmet-CPAP safely improves oxygenation in pregnant women with COVID-19 respiratory failure
27 Oct 2021Chronic constipation not a risk factor for later colorectal cancer
Individuals with chronic constipation do not seem to be at increased risk of developing subsequent colorectal cancer as compared with their peers who do not have the gastrointestinal condition, as reported in a study.